|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Echovirus IgM ELISA | Acid Labile Subunit (ALS) ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Complement System Classical Pathway ELISA Assay | Syndecan ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB05050 | E35 | TM09036 | COMPL CP310 RUO | 27188 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgM antibodies directed against ECHO viruses in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of Acid Labile Subunit (ALS) in serum and plasma (heparin, EDTA, citrate). For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Wieslab® COMPL CP310 is an enzyme immunoassay (ELISA) for the determination of functional classical complement pathway in human serum. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Syndecan-4 in serum, EDTA plasma and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Echovirus IgM | Immunoglobulin A (IgA) | sAPP Total | Human Phopsho Tau (217P) | Angiotensinogen (Intact) |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum, plasma, tissue homogenates and other biological fluids. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Cerebrospinal fluids | Serum, EDTA plasma, and urine. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 1.5 to 40.0 mU/mL ALS | Anti-Ustekinumab (Stelara®) | Inquire | 20 to 1280 pg/mL |
| Sensitivity | > 95% | 0.469 ng/ml | 0.06 ng/mL | 8.07 pg/mL | 0.093 ng/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 3 hrs (incubation) | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |